342 related articles for article (PubMed ID: 30892603)
21. [Low-frequency, low-dose oral psoralen-UV-A therapy for mycosis fungoides].
Kluwig D; Yazdi AS
Hautarzt; 2020 Jan; 71(1):81-82. PubMed ID: 31768559
[No Abstract] [Full Text] [Related]
22. A retrospective, descriptive study of patients with Mycosis fungoides treated by phototherapy (oral PUVA, NB-UVB) with a twice-weekly regimen at the Institute of Dermatology, Bangkok, Thailand, with an experiential timeline of 13 years.
Pattamadilok B; Poomputsar T
Photodermatol Photoimmunol Photomed; 2021 Jan; 37(1):49-55. PubMed ID: 32964521
[TBL] [Abstract][Full Text] [Related]
23. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
24. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
[TBL] [Abstract][Full Text] [Related]
26. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
27. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up.
Herrmann JJ; Roenigk HH; Hurria A; Kuzel TM; Samuelson E; Rademaker AW; Rosen ST
J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):234-42. PubMed ID: 7622650
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of topical PUVA treatment for refractory lesions of mycosis fungoides].
Yan Y; Xu C; Wang T; Liu J; Liu Y
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):859-62. PubMed ID: 26887519
[TBL] [Abstract][Full Text] [Related]
29. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
Shintani Y; Nishida E; Furuhashi T; Muramatsu S; Kubo R; Nakamura M; Watanabe S; Masuda H; Ikumi K; Matsumoto K; Yamazaki S; Morita A
J Dermatol; 2022 Feb; 49(2):239-245. PubMed ID: 34309912
[TBL] [Abstract][Full Text] [Related]
31. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
[TBL] [Abstract][Full Text] [Related]
32. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
Molin L; Thomsen K; Volden G; Groth O
Acta Derm Venereol; 1981; 61(1):47-51. PubMed ID: 6164214
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of doxycycline in the treatment of early stages of mycosis fungoides: a randomized controlled trial.
El Sayed H; Shalaby S; Abdel-Halim MRE; Aboelfadl DM; Samir N
J Dermatolog Treat; 2021 Jun; 32(4):424-431. PubMed ID: 31526286
[TBL] [Abstract][Full Text] [Related]
34. [Results of photochemotherapy in a series of 47 patients with mycosis fungoides].
Piccinno R; Caccialanza M; Mainardi L
G Ital Dermatol Venereol; 1989; 124(7-8):369-73. PubMed ID: 2628282
[TBL] [Abstract][Full Text] [Related]
35. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
36. Juvenile mycosis fungoides treated with bexarotene and PUVA.
Rodríguez-Vázquez M; García-Arpa M; González-García J
Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
[TBL] [Abstract][Full Text] [Related]
38. Long-term experience with low-dose interferon-alpha and PUVA in the management of early mycosis fungoides.
Rupoli S; Goteri G; Pulini S; Filosa A; Tassetti A; Offidani M; Filosa G; Mozzicafreddo G; Giacchetti A; Brandozzi G; Cataldi I; Barulli S; Ranaldi R; Scortechini AR; Capretti R; Fabris G; Leoni P;
Eur J Haematol; 2005 Aug; 75(2):136-45. PubMed ID: 16000130
[TBL] [Abstract][Full Text] [Related]
39. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
40. Phototherapy for hypopigmented mycosis fungoides in Asians.
Wongpraparut C; Setabutra P
Photodermatol Photoimmunol Photomed; 2012 Aug; 28(4):181-6. PubMed ID: 23017170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
